Lipoatrophy associated with lispro insulin in insulin pump therapy: An old complication, a new cause? [7]

Diabetes Care

Volumn 24, Issue 1, 2001, Pages 174-

  Griffin, Margaret E ^a,c   Feder, Arlene ^b   Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; HUMULOG; INSULIN LISPRO; INSULIN ZINC SUSPENSION; NEUTRAL INSULIN; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CHILD; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; LETTER; LIPOATROPHY;

EID: 0035132210     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.1.174     Document Type: Letter

References (4)

1. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin
2. Severe antibody-mediated human insulin resistance: Successful treatment with the insulin analog lispro: A case report
3. Lispro analog for the treatment of generalized allergy to human insulin
4. Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro